Ozempic Use Linked to Adverse Gastrointestinal Events Study Highlight: Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss In October 2023, researchers at the University of British Columbia published findings in the Journal of the American Medical Association (JAMA), which found an increased risk of adverse gastrointestinal events associated with GLP-1 receptor agonists used for weight loss
state except Mississippi and Louisiana
doi: 10.1002/jbmr.3947 44 XiXGaoYWangJZhengN
Related Reading Ozempic For Losing Weight Ozempic For Weight Loss 2 Average Weight Loss On Ozempic Ozempic For Type 2 Diabetes 2 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease
Guy Gourmet and A Man, A Pan, A Plan Readers Also Read 6 Editor-Approved Protein Powders Editor-Approved Creatine Supplements Multivitamins That Are Actually Worth Taking This Workout Will Banish Your Man Boobs